Description
LXS-196 is a selective inhibitor of protein kinase C (PKC). It is being investigated as a treatment for metastatic uveal melanoma, and may exhibit antitumor effects in other advanced tumors characterized by the overexpression of PKC.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LXS-196 is a selective inhibitor of protein kinase C (PKC). It is being investigated as a treatment for metastatic uveal melanoma, and may exhibit antitumor effects in other advanced tumors characterized by the overexpression of PKC.
| Cas No. | 1874276-76-2 |
|---|---|
| Purity | ≥98% |
| Formula | C22H23F3N8O |
| Formula Wt. | 472.48 |
| Chemical Name | LXS-196 |
| IUPAC Name | 3-Amino-N-[3-(4-amino-4-methyl-1-piperidinyl)-2-pyridinyl]-6-[3-(trifluoromethyl)-2-pyridinyl]-2-pyrazinecarboxamide |
| Synonym | LXS 196, LXS196, NVP-LXS196, Darovasertib |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Endogenous peptide hormone inolved in gastric e...
Diterpene found in coffee beans.
pan-Bcr-Abl tyrosine kinase inhibitor.
Docetaxel impurity
Synthetic prednisolone prodrug; glucocorticoid ...
Dihydropyridine; L-type Ca2+ channel blocker.
FIASMA, L-type Ca2+ channel blocker, D2 antagon...
PI3K and mTOR inhibitor.
Inhibitor of VEGFR1/2/3.
ATP competitive CDK inhibitor.
PKMYT1 inhibitor
Octapeptide derived from activity-dependent neu...
Phytoestrogen found in various plant sources; E...
Cholesterol ester transfer protein inhibitor.
ITC, used as chiral agent.
ACE inhibitor.
Optically active cysteine derivative found in A...
Viral M2 proton channel blocker, MAO-A, NET, NM...